Kidney failure, also known as renal failure, is a serious medical condition where the kidneys are no longer able to filter waste products from the blood. There are two main types of kidney failure: oliguric and anuric. Oliguric kidney failure is characterized by a decrease in the amount of urine produced, while anuric kidney failure is characterized by the complete absence of urine production. In this article, we will take a closer look at the differences between oliguric and anuric kidney failure.
Oliguric kidney failure is a type of acute kidney injury (AKI) that is characterized by a decrease in the amount of urine produced. This decrease in urine output is usually less than 400 milliliters per day. Oliguric kidney failure can be caused by a variety of factors, including dehydration, certain medications, and certain diseases. It can also be caused by certain types of kidney damage, such as glomerulonephritis or renal artery stenosis. When oliguric kidney failure occurs, the kidneys are unable to filter waste products from the blood. This can lead to an accumulation of toxins in the blood, which can cause a variety of symptoms. These symptoms can include fatigue, confusion, nausea, vomiting, and shortness of breath. If left untreated, oliguric kidney failure can be life-threatening.
Anuric kidney failure is a type of acute kidney injury (AKI) that is characterized by the complete absence of urine production. This means that no urine is produced by the kidneys, regardless of how much fluid is consumed. Anuric kidney failure can be caused by a variety of factors, including dehydration, certain medications, and certain diseases. It can also be caused by certain types of kidney damage, such as glomerulonephritis or renal artery stenosis. When anuric kidney failure occurs, the kidneys are unable to filter waste products from the blood. This can lead to an accumulation of toxins in the blood, which can cause a variety of symptoms. These symptoms can include fatigue, confusion, nausea, vomiting, and shortness of breath. If left untreated, anuric kidney failure can be life-threatening.
Oliguric and anuric kidney failure can be diagnosed by a variety of tests. These tests can include a physical examination, blood tests, urine tests, and imaging tests. The physical examination can help to identify any signs or symptoms of kidney failure, such as swelling or changes in skin color. Blood tests can help to measure levels of waste products in the blood, such as creatinine and urea. Urine tests can help to measure levels of waste products in the urine, such as creatinine and urea. Imaging tests, such as an ultrasound, can help to identify any structural changes in the kidneys.
The treatment of oliguric and anuric kidney failure depends on the underlying cause. If the cause is dehydration, then the patient may be given intravenous fluids to help restore fluid balance. If the cause is a medication, then the medication may be stopped or changed. If the cause is a disease, then the patient may be given medication to help control the disease. In some cases, dialysis may be necessary to help filter waste products from the blood.
Oliguric and anuric kidney failure are serious medical conditions that can be life-threatening if left untreated. Oliguric kidney failure is characterized by a decrease in the amount of urine produced, while anuric kidney failure is characterized by the complete absence of urine production. Both types of kidney failure can be diagnosed by a variety of tests, including physical examination, blood tests, urine tests, and imaging tests. The treatment of oliguric and anuric kidney failure depends on the underlying cause. It is important for patients to seek medical attention if they are experiencing any signs or symptoms of kidney failure.
1.
Why breast cancer survivors don't take their medicine, and what can be done about it.
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
FDA Approves New Drug Combo for RR Multiple Myeloma
4.
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
2.
HCC Codes in Oncology: Care Optimization in Plexiform Neurofibroma Management
3.
Understanding Mantle Cell Lymphoma Prognosis.
4.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
5.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
4.
Navigating the Complexities of Ph Negative ALL - Part VIII
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation